Largest pharmaceutical companies in the United States by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by net assets, at SEK 879.5B, ahead of Johnson & Johnson (SEK 829.3B) and Merck & Co (SEK 535B). Figures as of 20 Nov 2026, 06:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerSEK 879.5B
- Median
- SEK 6.6B
- Combined market value
- SEK 37.99T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SEK 879.5B | SEK 1.6T | SEK 280.08 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SEK 829.3B | SEK 6.54T | SEK 2,716.78 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 535B | SEK 3.33T | SEK 1,350.66 | 3.61% down | 45% up | ||
| 4 | Abbott LaboratoriesABT · Health Care | SEK 530.2B | SEK 1.83T | SEK 1,056.35 | 0.58% down | 16% down | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | SEK 317.9B | SEK 971.4B | SEK 9,390.27 | 2.35% down | 28% up | ||
| 6 | Eli LillyLLY · Health Care | SEK 269.9B | SEK 12.24T | SEK 13,740.74 | 2.29% down | 33% up | ||
| 7 | Vertex PharmaceuticalsVRTX · Health Care | SEK 189.8B | SEK 1.34T | SEK 5,295.05 | 2.94% down | 27% up | ||
| 8 | Bristol-Myers SquibbBMY · Health Care | SEK 187.9B | SEK 1.21T | SEK 593.31 | 2.05% down | 30% up | ||
| 9 | ViatrisVTRS · Health Care | SEK 149.6B | SEK 231.8B | SEK 202.18 | 1.97% down | 99% up | ||
| 10 | Royalty PharmaRPRX · Health Care | SEK 98.8B | SEK 396B | SEK 688.70 | 1.38% down | 79% up | ||
| 11 | United TherapeuticsUTHR · Health Care | SEK 72.2B | SEK 242.2B | SEK 5,685.99 | 3.16% down | 22% up | ||
| 12 | Elanco Animal HealthELAN · Health Care | SEK 66.6B | SEK 133.6B | SEK 267.37 | 1.54% down | 26% up | ||
| 13 | BioMarin PharmaceuticalBMRN · Health Care | SEK 61.9B | SEK 121B | SEK 624.63 | 0.02% down | 17% up | ||
| 14 | ZoetisZTS · Health Care | SEK 33.9B | SEK 333.8B | SEK 821.63 | 5.59% down | 26% down | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | SEK 10.3B | SEK 58.4B | SEK 2,918.15 | 3.94% down | 50% up | ||
| 16 | Legend BiotechLEGN · Health Care | SEK 10.2B | SEK 31.8B | SEK 163.74 | 0.92% down | 41% down | ||
| 17 | Praxis Precision MedicinesPRAX · Health Care | SEK 8.9B | SEK 88.4B | SEK 3,161.82 | 1.87% up | 86% up | ||
| 18 | Alnylam PharmaceuticalsALNY · Health Care | SEK 8B | SEK 201.4B | SEK 1,503.31 | 1.06% down | 66% down | ||
| 19 | Belite BioBLTE · Health Care | SEK 7.8B | SEK 62.4B | SEK 1,535.86 | 3.33% down | 43% up | ||
| 20 | InsmedINSM · Health Care | SEK 7.5B | SEK 322.3B | SEK 1,469.14 | 20.58% up | 40% down | ||
| 21 | Spyre TherapeuticsSYRE · Health Care | SEK 7.3B | SEK 94.3B | SEK 992.89 | 3.77% down | 332% up | ||
| 22 | Summit TherapeuticsSMMT · Health Care | SEK 6.7B | SEK 86B | SEK 107.50 | 0.67% up | 36% down | ||
| 23 | TG TherapeuticsTGTX · Health Care | SEK 6.6B | SEK 99.7B | SEK 659.82 | 1.88% down | 117% up | ||
| 24 | Corcept TherapeuticsCORT · Health Care | SEK 6.6B | SEK 72.3B | SEK 660.84 | 4.15% down | 10% down | ||
| 25 | Cogent BiosciencesCOGT · Health Care | SEK 6.5B | SEK 49.1B | SEK 282.11 | 0.25% down | 20% down | ||
| 26 | Protagonist TherapeuticsPTGX · Health Care | SEK 6.3B | SEK 82.3B | SEK 1,261.27 | 2.47% down | 51% up | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.1B | SEK 93.7B | SEK 4,034.80 | 0.34% down | 27% down | ||
| 28 | Edgewise TherapeuticsEWTX · Health Care | SEK 5.3B | SEK 45.8B | SEK 418.69 | 0.48% down | 86% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | SEK 5B | SEK 48.6B | SEK 862.71 | 1.01% up | 108% up | ||
| 30 | Ionis PharmaceuticalsIONS · Health Care | SEK 5B | SEK 46.1B | SEK 276.82 | 0.62% down | 63% down | ||
| 31 | Oruka TherapeuticsORKA · Health Care | SEK 4.8B | SEK 67.3B | SEK 992.28 | 1.91% up | 255% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 4.7B | SEK 62.8B | SEK 443.92 | 1.25% up | 13% up | ||
| 33 | Definium TherapeuticsDFTX · Health Care | SEK 3.4B | SEK 41B | SEK 299.81 | 1.24% up | 168% up | ||
| 34 | ErascaERAS · Health Care | SEK 3.3B | SEK 50.8B | SEK 144.62 | 3.34% up | 395% up | ||
| 35 | Mirum PharmaceuticalsMIRM · Health Care | SEK 3.2B | SEK 63.4B | SEK 971.33 | 3.27% up | 34% up | ||
| 36 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.4B | SEK 82.4B | SEK 1,187.84 | 1.88% down | 18% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | SEK 1.2B | SEK 47.2B | SEK 491.21 | 3.86% down | 45% up | ||
| 38 | Axsome TherapeuticsAXSM · Health Care | SEK 898M | SEK 72.6B | SEK 1,379.85 | 1.25% up | 6% down | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | -SEK 720M | SEK 75.8B | SEK 217.53 | 2.24% down | 90% up | ||
| 40 | VeradermicsMANE · Health Care | -SEK 1.2B | SEK 53.4B | SEK 1,265.03 | 0.38% down | 231% up | ||
| 41 | PTC TherapeuticsPTCT · Health Care | -SEK 2.1B | SEK 49.6B | SEK 593.16 | 3.16% down | 21% down | ||
| 42 | CytokineticsCYTK · Health Care | -SEK 6.7B | SEK 72.9B | SEK 523.34 | 0.27% up | 19% down | ||
| 43 | BridgeBio PharmaBBIO · Health Care | -SEK 21.2B | SEK 154.9B | SEK 795.08 | 0.22% up | 21% up | ||
| 44 | AbbVieABBV · Health Care | -SEK 33.3B | SEK 5.1T | SEK 2,883.57 | 0.86% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1699 SEK).
Questions and answers
Which pharmaceutical companies in the United States rank first by net assets?
Pfizer (SEK 879.5B), Johnson & Johnson (SEK 829.3B) and Merck & Co (SEK 535B) are the top three of the 44 pharmaceutical companies in the United States ranked by net assets as of 20 Nov 2026, 06:27 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by net assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by net assets have a combined market value of SEK 37.99T as of 20 Nov 2026, 06:27 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.